Coronary heart disease risk factor levels in eastern and western Finland from 1980 to 2011 in the cardiovascular risk in Young Finns study by Vähämurto, Lauri et al.
Contents lists available at ScienceDirect
Atherosclerosis
journal homepage: www.elsevier.com/locate/atherosclerosis
Coronary heart disease risk factor levels in eastern and western Finland from
1980 to 2011 in the cardiovascular risk in Young Finns study
Lauri Vähämurtoa,∗, Katja Pahkalaa,b, Costan G. Magnussena,c, Nina Hutri-Kähönend,
Mika Kähönene, Tomi Laitinenf, Leena Taittoneng, Päivi Tossavainenh, Terho Lehtimäkii,
Eero Jokinenj, Risto Telamak, Tapani Rönnemaal, Jorma Viikaril, Markus Juonalaa,l,
Olli T. Raitakaria,m
a Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
b Paavo Nurmi Centre, Sports and Exercise Medicine Unit, Department of Physical Activity and Health, University of Turku, Turku, Finland
cMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia
dDepartment of Pediatrics, University of Tampere and Tampere University Hospital, Tampere, Finland
e Faculty of Medicine and Life Sciences Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere,
Tampere, Finland
fDepartment of Clinical Physiology and Nuclear Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
g Vaasa Central Hospital, Vaasa, Finland
hDepartment of Pediatrics, University of Oulu, Oulu, Finland
iDepartment of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of
Tampere, Finland
jDepartment of Pediatric Cardiology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
k LIKES-Research Center for Sport and Health Sciences, Jyväskylä, Finland
l Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland
mDepartment of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland
H I G H L I G H T S
• Eastern Finns had higher blood pressure, total cholesterol and blood glucose from 1980 to 2011.• Currently, the CHD risk factor profile is similar between participants with childhood residency in east or west.• Results suggest that CHD mortality in the next decades might remain higher in eastern compared to western Finns.








A B S T R A C T
Background and aims: In the 1960s and 1970s, Finland, mortality due to coronary heart disease (CHD) was over
30% higher among Finns residing in the east of the country compared with those residing in the west. Today,
CHD mortality remains 20% higher among eastern Finns. The higher incidence of CHD mortality among eastern
Finns has largely been explained by higher risk factor levels. Using a unique longitudinal cohort, we aimed to
determine if participants who resided in eastern Finland during childhood had higher CHD risk factors in
adulthood and from childhood to adulthood.
Methods: The study population included 2063 participants of the Cardiovascular Risk in Young Finns Study,
born during the period 1962–1977, with risk factor data available from baseline (1980) when participants were
aged 3–18 years, and had risk factor data collected again in adulthood (2011) when aged 34–49 years.
Results: Adult CHD risk factor profile was similar for those who resided in eastern or western Finland in
childhood. Over life-course from 1980 to 2011, those subjects with childhood residency in eastern Finland had,
on average, higher systolic (p = 0.006) and diastolic (p = 0.0009) blood pressures, total (p = 0.01) and LDL-
cholesterol (p = 0.01), triglycerides (p = 0.04), apoB (p = 0.02), and serum glucose (p<0.0001) than those
who resided in western Finland in childhood.
Conclusions: Our sample of adult Finns aged 34–49 years had a similar CHD risk factor profile irrespective of
whether they resided in eastern or western Finland during their childhood. However, when considering
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participants risk factor profiles over a 31-year period, those who resided in eastern Finland in childhood were
associated with a less favorable CHD risk factor profile than those who resided in western Finland in childhood.
The observed differences suggest that future CHD mortality might remain higher in eastern Finland compared
with western Finland.
1. Introduction
Coronary heart disease (CHD) is a major cause of death globally. In
the 1960s, CHD mortality was found to be high in Finland compared to
other countries [1], especially among men born in eastern Finland. The
excess CHD risk observed amongst those residing or born in eastern
Finland compared with western Finland was largely explained by a
higher prevalence of risk factors: hypercholesterolemia, hypertension,
and smoking. In response to the high rates of CHD in Finland and the
observed east-west difference, a national program called the North
Karelia project was launched in the 1970s aimed to modify lifestyle
factors and improve risk factor levels to decrease CHD, particularly in
eastern Finland [2]. From 1972 to 2012, age-adjusted CHD mortality in
working-age men decreased by 82% and among working-age women by
84% in eastern Finland [3]. The major part of the decline in CHD
mortality could be explained by the decrease in serum total cholesterol
in men and the decrease in systolic blood pressure and serum total
cholesterol in women [3]. CHD mortality also decreased in western
Finland, but not as dramatically as observed in eastern Finland. Cur-
rently, eastern Finns still have approximately 20% higher CHD mor-
tality than western Finns (National Institute for Health and Welfare;
2012).
The Cardiovascular Risk in Young Finns Study is a nationwide on-
going study of Finnish children and adolescents that began in 1980 to
examine atherosclerosis precursors [4]. One of the key purposes has
been to study differences in cardiometabolic risk markers between
eastern and western Finns. We have previously shown that participants
who were resident in eastern Finland in childhood had, on average,
higher total cholesterol in childhood [5], and higher blood pressure and
total cholesterol as adults in 2001 [6] than those who resided in wes-
tern Finland in childhood. By 2007, those currently living in eastern
Finland had higher blood pressure than those who were currently living
in western Finland [7].
Although regularly studied cross-sectionally, differences in CHD risk
factors between eastern and western Finns in 2010s are not known.
Also, the east-west differences in CHD risk factors have not been in-
vestigated in a longitudinal cohort over 31-years of follow-up from
childhood to adulthood. Therefore, our aim was to investigate current
east-west differences in CHD risk factors and to assess the role of east-
west residency in childhood. We hypothesized that risk factor
differences between those resident in eastern or western Finland at
baseline would be marginal in adulthood but those with baseline
eastern Finland residency would have higher risk factor levels from
childhood to adulthood.
2. Materials and methods
2.1. Participants
The Cardiovascular Risk in Young Finns Study is a population-based
follow-up study on cardiovascular risk factors in Finland [4]. In 1980,
children and adolescents aged 3–18 years were randomly chosen from
the population register to form a representative sample of Finnish
children. 3596 children participated in the first cross-sectional study
carried out in five Finnish university cities with medical schools (Hel-
sinki, Kuopio, Oulu, Tampere and Turku) and their rural surroundings.
Since 1980, regular follow-ups have been performed. We used the data
from follow-up studies with extensive data on anthropometry, blood
pressure measurements and biochemical analyses (1980, 1983, 1986,
2001, 2007, 2011) (Fig. 1). 2063 participants attended the 2011 follow-
up clinical examination. The study has been approved by the Joint
Commission on Ethics of the Turku University and the Turku University
Central Hospital and informed consent was obtained from all partici-
pants or their parents.
In this study, participants were grouped according to their baseline
(1980) residency. The areas of Kuopio and Oulu were considered
eastern, Helsinki, Tampere and Turku as western [8]. Geographically
more accurate terms would be southwestern and northeastern but due
to historical reasons and simplicity, we have used the terms eastern and
western.
2.2. Anthropometry, blood pressure, biochemical analyses
Weight, height and waist circumference were measured and body
mass index (BMI) calculated as weight (kg)/(height2 (m2)). Blood
pressure was measured with participants seated after a 5-min rest using
a standard mercury sphygmomanometer in 1980 and 1983 and using a
random zero sphygmomanometer at subsequent follow-ups. The
average of three measurements was used. For those aged 3-years in
1980, only systolic blood pressure was measured using an ultrasound
Fig. 1. Study design of the Cardiovascular Risk in Young Finns Study (follow-ups with extensive data on anthropometry, blood pressure measurements and bio-
chemical analyses).
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device (Arteriosonde, Roche). Venous blood samples were drawn after
an overnight fast in childhood and adulthood and measured and ana-
lyzed with standard enzymatic methods [4]. Computationally estimated
values were used in 1980–86 for apolipoproteins A1 and B [9] and
immunoturbidimetrically measured values after 1986.
2.3. Lifestyle risk factors and socioeconomic status
Cigarette smoking, alcohol consumption, physical activity and so-
cioeconomic status (SES) were determined from self-report ques-
tionnaires. Those smoking daily were classified as smokers. Alcohol
consumption was measured as standard doses per week. Number of
school years completed was used as a measure of participant SES in
adulthood. Parental SES was estimated by two measures: school years
of the more-educated parent (1= less than 9 years, 2= 9–12 years,
3= over 12 years); and parental income (1= the lowest quartile,
2= the second and the third quartiles, 3= the highest quartile).
2.4. Definition of hypertension, metabolic syndrome, type 2 diabetes and
fatty liver
Hypertension was classified as systolic blood pressure ≥140mmHg
or diastolic blood pressure ≥90mmHg or the use of anti-hypertensive
medication. The metabolic syndrome was defined according to the
Harmonized criteria [10]. The definition included the following cri-
teria: waist circumference ≥102 cm in men and ≥88 cm in women,
fasting serum glucose ≥5.6mmol/l or treatment, hypertriglyceridemia
≥1.7mmol/l, HDL-cholesterol ≤1.0mmol/l in men and ≤1.3mmol/l
in women, and hypertension as systolic blood pressure ≥130mmHg or
diastolic blood pressure ≥85mmHg or the use of anti-hypertensive
medication. A diagnosis required that any three of the five criteria be
present. Pregnant women in 2007 (n=37) and/or in 2011 (n= 13)
were excluded from analyses involving the metabolic syndrome in
adulthood. Participants were diagnosed as having type 2 diabetes if
they had serum fasting glucose ≥7mmol/l or GHbA1c≥6.5% or self-
reported diabetes or use of medication [11]. Hepatic steatosis was
evaluated in 2040 participants using a validated protocol [12] and
Sequoia 512 ultrasound mainframes (Acuson, Mountain View, CA,
USA) with 4.0MHz adult abdominal transducers. Hepatic steatosis was
determined according to liver-to-kidney contrast, parenchymal bright-
ness, deep beam attenuation, and bright vessel walls. The presence of
hepatic steatosis was assessed visually by a trained ultrasonographer
who was not-blinded to participant details. Participants were classified
into fatty liver and normal liver groups [13].
2.5. Statistical analyses
CHD risk factors in 2011 for participants are displayed stratified by
sex and baseline residency (eastern or western). Continuous variables
are presented as means (standard deviation, SD) for normally dis-
tributed variables or medians (interquartile range) for variables with a
skewed distribution. Categorical variables are presented as proportions.
P-values for CHD risk factors in 2011 were analyzed using t-tests. Non-
normally distributed risk factors were first log-transformed. Categorical
risk factors were analyzed using the chi-square test.
For longitudinal analyses, CHD risk factors Z-scores were generated
for each follow-up year from 1980 to 2011. Non-normally distributed
risk factors (BMI, triglycerides, insulin, glucose) were first log-trans-
formed. The longitudinal differences between participants with
eastern/western baseline residency were analyzed with repeated mea-
sures linear mixed models. Models were adjusted for age and sex and
the year of study using an unstructured covariance structure. As there
were no sex*east-west baseline residency interactions, data for males
and females were analyzed together. We further analyzed the
Table 1
Coronary heart disease risk factors in 2011 (mean ± SD or median [interquartile range]*) according to the place of residence at baseline in 1980.
Males (n= 934) Females (n= 1128)
Eastern 1980 Western 1980 Eastern 1980 Western 1980 pa
Mean SD Mean SD Mean SD Mean SD
N range 362–434 424–496 449–527 517–588
Age (years) 41.8 5.0 41.8 5.1 42.2 4.9 41.7 5.0 0.94
Height (cm) 179 7 180 7 165 6 167 6 0.0005
Birth weight (g) 3570 600 3600 550 3460 520 3480 520 0.39
BMI (kg/m2)* 26.3 5.1 26.3 5.4 25.2 6.7 24.9 6.6 0.76
Waist (cm) 96.2 12.2 97.6 13.2 87.4 14.6 87.9 13.5 0.13
Systolic blood pressure (mmHg) 123 13 123 14 115 13 116 15 0.61
Diastolic blood pressure (mmHg) 78 10 77 11 72 9 72 10 0.73
Hypertension (%) 24.7 24.1 15.9 14.6 0.58
Total cholesterol (mmol/L) 5.31 0.99 5.33 1.03 5.11 0.89 5.04 0.88 0.47
HDL-cholesterol (mmol/L) 1.19 0.28 1.21 0.31 1.43 0.32 1.43 0.33 0.71
LDL-cholesterol (mmol/L) 3.45 0.91 3.42 0.89 3.17 0.74 3.12 0.76 0.29
ApoA1 (g/L) 1.52 0.21 1.52 0.22 1.66 0.24 1.64 0.24 0.27
ApoB (g/L) 1.15 0.29 1.16 0.30 0.99 0.25 0.97 0.26 0.62
Triglycerides (mmol/L)* 1.26 0.92 1.26 1.12 0.95 0.51 0.95 0.51 0.87
Insulin (mU/L)* 8.04 7.05 7.57 7.83 6.94 6.57 6.79 6.89 0.91
Glucose (mmol/L)* 5.47 0.63 5.47 0.63 5.15 0.64 5.15 0.64 0.31
Metabolic syndrome (%) 24.1 27.4 17.5 17.7 0.36
Type 2 diabetes (%) 3.7 4.4 3.8 3.8 0.73
Fatty liver (%) 27.4 29.5 12.5 9.3 0.69
Smokers (%) 19.4 15.3 13.4 12.5 0.16
Physical activity index (range 5–15) 8.95 1.83 8.80 1.91 9.10 1.78 9.16 1.91 0.65
SES (school years) 14.9 3.6 14.8 4.0 15.7 3.2 15.7 3.5 0.74
Parental SES/school years (range 1–3) 1.87 0.80 1.94 0.78 1.78 0.76 1.92 0.78 0.006
Parental SES/income (range 1–3) 1.90 0.72 2.03 0.67 1.90 0.73 2.02 0.68 < 0.0001
Alcohol consumption (doses per week) 4 9 6 10 2 5 2 5 0.20
SES: socioeconomic status. Parental SES: higher value refers to more school years/higher income.
a p-values for east-west difference in analyses where sexes are combined.
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longitudinal differences in CHD risk factors with adjustment for par-
ental SES (school years and income status) at baseline as it was different
between participants with eastern or western baseline residency and is
known to associate with traditional CHD risk factors. The analyses were
performed with SAS version 9.3 (SAS institute, Inc, Cary, NC). A two-
tailed p-value of< 0.05 was considered statistically significant.
3. Results
3.1. Coronary heart disease risk factors in 2011 according to baseline
residency
Males and females were divided equally among the east-west groups
(p= 0.71) and the mean age between the groups was similar (Table 1).
Those resident in eastern Finland at baseline were, on average, shorter
than those who were resident in western Finland at baseline. Irre-
spective of baseline residency, there were no differences in CHD risk
factors in 2011 between participants. The prevalence of type 2 diabetes,
Fig. 2. Longitudinal analyses of coronary heart disease risk factors from 1980 to 2011.
N is given as number of participants with data from at least one study year. p value is for the longitudinal analyses. Z score is given as mean and 95% confidence
intervals. *p value < 0.05 for east–west difference at a single follow-up year. (A) BMI, systolic and diastolic blood pressure from 1980 to 2011 according to baseline
residency in 1980. Y-axis displays mean Z-score with 95% confidence intervals (eastern, continuous line, N=1749–1750; western, dash line, N= 1840–1842). 1
standard deviation equals 12.2 (1980) – 14.1 (2011) mmHg for systolic blood pressure and 9.6 (1980) – 10.5 (2011) mmHg for diastolic blood pressure. (B) Total,
LDL-cholesterol, and HDL-cholesterol from 1980 to 2011 according to baseline residency in 1980 (eastern, continuous line, N=1750; western, dash line, N= 1838).
1 standard deviation equals 0.92 (1980) - 0.95 (2011) mmol/l for total cholesterol, 0.83 (1980) - 0.83 (2011) mmol/l for LDL-cholesterol and 0.31 (1980) - 0.33
(2011) mmol/l for HDL-cholesterol. (C) Triglycerides, apoA and apoB from 1980 to 2011 according to baseline residency in 1980 (eastern, continuous line,
N=1726; western, dash line, N=1808). 1 standard deviation equals 0.22 (1980) - 0.24 (2011) mmol/l for apoA and 0.18 (1980) - 0.29 (2011) mmol/l for apoB. (D)
Serum glucose from 1986 to 2011 and insulin from 1980 to 2011 according to baseline residency in 1980 (eastern, continuous line, N=1749; western, dash line,
N=1838).
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hypertension, and fatty liver were also similar between those resident in
eastern and western Finland at baseline. Parental SES, as indicated by
parent school years completed and family income at baseline, was
higher in those resident in western compared with eastern Finland.
We further analyzed the prevalence of hepatic steatosis among
males and females and in association with alcohol consumption (data
not shown). Prevalence among all men was higher than among women
(28.5% vs. 10.8%, p<0.0001). Prevalence of hepatic steatosis was
higher in men than in women also among those who consumed less
than 10 standard doses of alcohol per week (26.3% vs. 9.8%, p= 0.02).
Those who consumed 10 or more standard doses of alcohol per week
(263 men, 96 women) had higher prevalence of hepatic steatosis than
those who consumed less than 10 standard doses per week (657 men
and 1007 women) both among men (33.8% vs. 26.3%, p = 0.02) and
women (20.8% vs. 9.8%, p = 0.002).
3.2. Coronary heart disease risk factors from 1980 to 2011 according to
baseline residency
3.2.1. Anthropometric measurements
From 1980 to 2011, BMI was not statistically different between
those resident in eastern or western Finland at baseline. Those with
eastern baseline residency had significantly higher, on average, systolic
and diastolic blood pressures from 1980 to 2011 compared with those
residing in western Finland at baseline. As indicated by the 95% con-
fidence intervals, eastern participants had higher systolic blood pres-
sure in 1980, 2001, and 2007 and higher diastolic blood pressure in
1980, 1986, 2001 and 2007 compared with western residents. East-
west difference in blood pressure was largest in 2007 but was not ap-
parent in 2011 (Fig. 2A).
3.2.2. Lipids and apolipoproteins
On average, those residing in eastern Finland at baseline had higher
total and LDL-cholesterol (Fig. 2B), triglycerides and apoB (Fig. 2C)
compared with western participants during the 31 years of follow-up.
As indicated by the 95% confidence intervals, concentrations were
Fig. 2. (continued)
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higher among eastern participants in 1980, 1983, and 1986 for trigly-
cerides, after which the differences were no longer significant. From
1980 to 2011, we observed no east-west difference, on average, for
HDL-cholesterol and apoA. At single follow-up years, we only observed
a difference for apoA in 1983.
3.2.3. Glucose metabolism
Participants with baseline residency in eastern Finland had higher
serum glucose on average compared with those with western baseline
residency in the longitudinal analyses. As indicated by the 95% con-
fidence intervals, serum glucose was higher among eastern participants
in 1986 but was similar between eastern and western groups in 2001,
2007, and 2011. In the longitudinal analyses there was no east-west
difference in serum insulin. As indicated by the 95% confidence inter-
vals, serum insulin was similar between eastern and western partici-
pants from 1980 to 2011 except that eastern residents had higher values
in 1983 (Fig. 2D).
We further analyzed the longitudinal differences in CHD risk factors
with adjustment for baseline parental SES (school years and income
class) in addition to adjustment for age and sex. Except for triglycerides,
the observed east-west differences in risk factors remained statistically
significant.
4. Discussion
Compared with those who resided in western Finland in childhood,
residing in eastern Finland in childhood was associated with higher
average blood pressure, total and LDL-cholesterol, triglycerides, apoB,
and serum glucose from 1980 to 2011. In 2011, there were no differ-
ences in traditional CHD risk factors between eastern or western re-
sidents.
We found no evidence for significant differences in hepatic steatosis
between eastern and western Finns. Instead we found higher prevalence
of hepatic steatosis in men compared with women, also among those
used low amounts of alcohol. In our previous study, risk of fatty liver
was higher among males, those of older age, and those with elevated
levels of waist circumference, alanine aminotransferase, BMI, trigly-
cerides, systolic blood pressure, insulin, higher alcohol consumption
and/or lower physical activity [13].
The heightened CHD mortality among eastern Finns in the 1960s
was accompanied by a higher prevalence of hypertension, smoking and
hypercholesterolemia compared with individuals from other nations
and those from western Finland [1]. In the nationwide FINRISK-study
in 1982, total cholesterol levels among men and systolic blood pressure
levels in both men and women in eastern Finland remained compara-
tively higher on average than among their counterparts from western
Finland, but ten years later these east-west differences had disappeared
[14]. In our prior study, eastern residents had, on average, higher total
cholesterol levels at baseline (1980) [15] and in 2001 had higher total
cholesterol and blood pressure levels [6] than western residents at
baseline. In 2007, those currently living in eastern Finland had higher
blood pressure on average than those living in the west [7]. Our
longitudinal findings reported here indicate that despite similar CHD
risk factor levels currently existing between eastern and western Finns,
there remains a residual burden or legacy effect of higher CHD risk
factors from past decades in the east, as the earlier also suggested
[3,16]. Carotid intima-media thickness, associated with future CV
events [17], has also been found higher in eastern Finns compared with
western Finns in other studies [16] and in our study [7].
The narrowing of east-west differences in CHD risk factors has oc-
curred in conjunction with an overall decline in CHD risk factor levels
and CHD mortality in Finland. CHD mortality in Finland fell by over
80% among working-age men and women from 1972 to 2012 [3]. In
impact analyses of the FINRISK-cohort, the diminishing CHD risk factor
levels in the population accounted for over 95% of the reduction in
CHD mortality in the 1970s [18] and two thirds of the CHD mortality
reduction from 2002 to 2012. The remaining last third of the decline in
CHD mortality in the latest decade was due to changes in other primary
risk factors such as diet and physical activity, and secondary prevention
with medication and the treatment of acute cardiac events [3]. In the
latest FINRISK-study, the CHD mortality in 35–74 year-old Finns was
17% lower in western men and 15% lower among western women than
in eastern Finland [3]. According to the National Institute for Health
and Welfare's data, eastern Finns continued to have 20% higher CHD
mortality than Western Finns in 2012. The WOSCOPS- study found that
treatment with pravastatin for 5-years reduced cardiovascular mortality
and hospitalizations over a 20-year period, even after the dis-
continuation of the drug [19]. The higher CHD mortality still found in
eastern Finns compared with western Finns supports the legacy effect of
an earlier, higher risk CHD profile.
In this study, we chose to study east-west differences in CHD risk
factors according to baseline residency. Migration from eastern to
western Finland has been notable. For example, we have previously
found that Young Finns participants who migrated from east-to-west
between 1980 and 2007 had lower CHD risk factors and carotid intima-
media thickness compared with those who remained in the east [7].
Therefore, the contemporary and long-term east-west differences might
be more pronounced than we have shown in the present study.
Participants who resided in the east at baseline had lower parental
socioeconomic status at baseline and were shorter after 31 years of
follow-up than those who resided in the west at baseline. Lower so-
cioeconomic status has been found to associate with poorer CHD risk
profile [20]. Short stature may associate with lower socioeconomic
status [21] but overall, the association of height with CHD risk remains
unclear [22,23].
Earlier studies have suggested that genetic differences within
Finland could contribute to the observed east-west difference in CHD
risk factor levels [5]. Researchers have concluded that Finland was
settled from two directions [24] and genetic differences between
eastern and western Finns are larger than between some nations in
Europe. Some studies have suggested [25] that being born in East
Finland is a more important CHD risk factor than is living there, which
might be due to genetics, epigenetics or inherited health behaviors.
Another cohort of the Finnish population, the national FINRISK/
FINDIET-study has studied diet regularly since 1982 [26]. In their
study, saturated fat intake as energy percent decreased from 20% in
1982 to 12% in 2007 and increased to 14% in 2012. The effect of
dietary changes counted for 0.3–0.5 mmol/l change in serum total
cholesterol in the FINRISK-study between 1982 and 2012. Analyses for
effect of dietary changes on total cholesterol differences specifically
between eastern and western Finns have nevertheless not been re-
ported. The FINDIET-study [27] also found that salt intake among
Finnish population reduced from 13 g/day to 8–9 g/day in men and
11 g/day to 7 g/d in women between 1979 and 2007. As the Young
Finns Study participants are representative of the Finnish population
we suspect that their dietary choices and nutritional intakes are in ac-
cordance with the FINRISK/FINDIET-studies.
This study has some limitations. The loss to follow-up is inevitable
in longitudinal studies. However, we have found that risk factor levels
are essentially similar among participants and non-participants at
baseline [4]. Because of our young study population we cannot yet
study the east-west differences in CHD and other clinical end-points.
Further, we are unable to provide systematically similar data on a given
nutrient, food item or e.g. salt intake throughout the study years as the
methods used to assess diet have changed during the 30 years of follow-
up. Also the questionnaires assessing physical activity habits have been
modified during the follow-up to capture as well as possible the beha-
viour in the given age group. A further limitation is that questionnaires
were used to assess data on lifestyles and e.g. consumption of alcohol.
The prospective study design, follow-up time extending 30 years and
detailed phenotyping of Young Finns participants are the main
strengths of this study.
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In conclusion, we found that CHD risk profile in 2011 was similar
irrespective of participant's eastern or western residency in childhood.
However, in longitudinal analyses from 1980 to 2011, participants who
were resident in eastern Finland at baseline had a higher CHD risk
profile, on average, compared with those resident in western Finland at
baseline. These findings suggest that we might see a higher prevalence
of clinical end-points in eastern Finns than in western Finns in the fu-
ture owing to a legacy effect of higher CHD risk profile in childhood.
However, the similar risk factor profile observed today, suggests the
excess CHD mortality observed amongst eastern Finns might diminish
in the future.
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